Johnson & Johnson's Lung Cancer Therapy Promises Market Shift Johnson & Johnson's new combination lung cancer therapy shows promising results, potentially changing the standard of care and impacting the pharmaceutical market.
Novo Nordisk, Amgen, & Eli Lilly Navigate Weight-Loss Drug Challenges Explore how Novo Nordisk, Amgen, and Eli Lilly tackle competition and supply constraints in the weight-loss drug market. Discover the latest industry insights.